# Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder

> **NCT01663974** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 125 (actual)

## Conditions studied

- Bipolar Disorder
- Sub-syndromal Symptoms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01663974
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2015-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01663974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01663974, "Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01663974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*